MA
RMD icon

Momentum Advisors’s ResMed RMD Stock Holding History

Momentum Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$377K Sell
1,811
-2
-0.1% -$439 0.38% 50
2022
Q3 		$396K Buy
+1,813
New +$413K 0.44% 43

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Momentum Advisors's RMD Position: Q4 2022 in Review

Momentum Advisors reduced its ResMed (RMD) stake by 0.11% in Q4 2022, selling an estimated $439 and leaving 1,811 shares worth $377K. The position accounts for 0.38% of the portfolio, ranked #50.

Momentum Advisors first reported a position in RMD in Q3 2022 and has held it in 2 quarters since. The position peaked at $396K in Q3 2022. 731 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

  • Momentum Advisors held 1,811 shares of ResMed worth $377K as of Q4 2022.
  • Momentum Advisors sold 2 ResMed shares in Q4 2022, an estimated $439.
  • ResMed made up 0.38% of Momentum Advisors's portfolio in Q4 2022, its #50 holding.
  • Momentum Advisors first reported a position in ResMed in Q3 2022 and has held it in 2 quarters since.
  • Momentum Advisors's ResMed position peaked at $396K in Q3 2022.
  • 731 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on Momentum Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.